ABSTRACT
Introduction The circadian clock regulates multiple aspects of human physiology including immunity. People have a circadian preference termed chronotype. Those with an evening preference may be better suited to shift work, but also carry higher risk of adverse health. Shift work leads to misalignment of circadian rhythms and is associated with increased risk of inflammatory disease such as asthma and cancer. Here, we investigate the association between chronotype, shift work and rheumatoid arthritis (RA).
Methods The associations between exposures of shift work and chronotype on risk of RA were studied in up to 444,210 UK Biobank participants. Multivariate logistic regression models were adjusted for covariates including age, sex, alcohol intake, smoking history and BMI.
Results After adjusting for covariates, individuals with a morning chronotype had lower odds of having RA (OR 0.93, 95% CI 0.88 to 0.99) when compared to intermediate chronotypes. The association between morning chronotype and lower odds of RA persisted with a more stringent RA case definition (Covariate-adjusted OR 0.89, 95% CI 0.81 to 0.97). Shift workers had a higher odds of RA (OR 1.22, 95% CI 1.1 – 1.36), that attenuated to the null after covariate adjustment.
Conclusions These data implicate circadian rhythms in RA pathogenesis. Further studies are required to determine the mechanisms underlying this association and understand the potential impact of shift work on chronic inflammatory disease and its mediating factors.
What is already known about this subject?
Chronotype impacts a person’s ability to adapt to shift work, which contributes to circadian misalignment and is associated with adverse health outcomes including asthma, diabetes and cancer
What does this study add?
People with morning chronotype have a lower likelihood of RA, compared to intermediate chronotypes
Shift workers have higher likelihood of RA, compared to day workers, but this relationship may be mediated or confounded by factors such as smoking and BMI
How might this impact on clinical practice or future developments?
Chronotype is easy to assess and could be combined with other factors to determine an individual’s risk of developing RA and influence decisions about undertaking shift work
Growing evidence that common chronic inflammatory disorders are affected by circadian misalignment generates further need to investigate the impact of chronotype and shift work on immune function
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
DWR is funded via MRC programme grant MR/P023576/1; Wellcome Trust (107849/Z/15/Z); TDB is an MRC Clinical Research Training Fellow (MR/S02199X/1); JEG is a Versus Arthritis Senior Research Fellow (22625) and work in her lab is funded by Versus Arthritis and the MRC (MR/S002715/1 and MR/P023576/1). RJM is funded via MRC programme grant (MR/P023576/1) and Wellcome Trust grant (107849/Z/15/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The source data are available at https://www.ukbiobank.ac.uk/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: DWR is funded via MRC programme grant MR/P023576/1; Wellcome Trust (107849/Z/15/Z); TDB is an MRC Clinical Research Training Fellow (MR/S02199X/1); JEG is a Versus Arthritis Senior Research Fellow (22625) and work in her lab is funded by Versus Arthritis and the MRC (MR/S002715/1 and MR/P023576/1). RJM is funded via MRC programme grant (MR/P023576/1) and Wellcome Trust grant (107849/Z/15/Z).
Conflicts of interests: None declared
Data Availability
All data produced in the present work are contained in the manuscript
